Surendra K. Ajjarapu
CEO and Chairman at Tevogen Inc.
Sits on 4 boards. Last updated September 28, 2026
Time on boards
- Boards served
- 4
- Current seats
- 4
- Board service
- 11 years
- Director since
- 2023
11 years of board service in total across 4 boards, counting each seat separately. Longest: Tevogen Inc., 3 years.
Tevogen Inc.
Director · CEO and Chairman
Aspire-Lakewood Holdings Inc.
Director · Chief Executive Officer
Scienture Holdings Inc.
Director · Chairman and CEO
DataMeds AI Inc.
Director
Chief executive roles
Scienture Holdings Inc.
· Chairman and CEO
Dates unknown
Aspire-Lakewood Holdings Inc.
· Chief Executive Officer
Since August 2023
Tevogen Inc.
· CEO and Chairman
2023 – 2024
· Former
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 22, 2026 | DataMeds AI Inc. | In-the-money exercise | +100,000 | $0.01 | $1,000 |
| Mar 31, 2026 | DataMeds AI Inc. | Grant or award | +5,000,000 | $0.20 | $1,000,000 |
| Mar 21, 2025 | DataMeds AI Inc. | Grant or award | +2,882,247 | — | — |
| Mar 21, 2025 | DataMeds AI Inc. | Grant or award | +600,000 | — | — |
| Mar 21, 2025 | DataMeds AI Inc. | Grant or award | +600,000 | — | — |
| Jan 5, 2024 | Scienture Holdings Inc. | Grant or award | +150,000 | — | — |
| Jun 7, 2023 | Tevogen Inc. | Grant or award | +1,000,000 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.